Instrument Inactif

Communiqués Curis, Inc. Nasdaq

Actions

US2312691015

Recherche biotechnologique et médicale

Communiqués

14/08	Curis: Q2 Earnings Snapshot	AQ
13/08	Curis, Inc. Announces Pricing of $5.6 Million Public Offering	PR
30/07	Curis Doses First Five Patients in TakeAim CLL Study	PR
22/07	Curis Announces Positive Emavusertib Update	PR
06/07	Curis Consents First Six Patients in TakeAim CLL Study	PR
26/06	Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split	PR
12/05	Curis: Q1 Earnings Snapshot	AQ
12/05	Curis Provides First Quarter 2026 Business Update	PR
05/05	Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026	PR
19/03	Curis: Q4 Earnings Snapshot	AQ
19/03	Curis Provides Fourth Quarter 2025 Business Update	PR
12/03	Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026	PR
12/01	Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds	AQ
09/01	Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds	PR
07/01	Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds	PR
09/12	Curis Provides Updated Data from its Frontline AML Triplet Study	PR
14/11	Curis to Present at Upcoming 30th Annual SNO Meeting	PR
06/11	Curis: Q3 Earnings Snapshot	AQ
06/11	Curis Provides Third Quarter 2025 Business Update	PR
30/10/25	Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025	PR
06/10/25	Curis Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	AQ
03/10/25	Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	PR
02/09/25	Curis to Present at Upcoming Healthcare Conferences in September	PR
05/08/25	Curis: Q2 Earnings Snapshot	AQ
05/08/25	Curis Provides Second Quarter 2025 Business Update	PR